Armata Pharmaceuticals, Inc. ( NYSEAMERICAN:ARMP – Get Free Report ) was the recipient of a significant decrease in short interest during the month of August. As of August 31st, there was short interest totalling 186,300 shares, a decrease of 11.7% from the August 15th total of 211,100 shares. Based on an average daily volume of 168,700 shares, the short-interest ratio is currently 1.1 days. Currently, 1.7% of the shares of the stock are short sold. Analyst Ratings Changes Separately, HC Wainwright reaffirmed a 'buy' rating and issued a $7.

https://www.dailypolitical.com/2023/09/18/armata-pharmaceuticals-inc-nyseamericanarmp-sees-large-decline-in-short-interest.html

#dailypolitical